Target-Centric AI Drug
Discovery Meets the Future

Target-centric approach enables the rational design of next-generation therapeutics (—such as PPI modulators and molecular glue degraders—) expanding treatment options for resistant and previously undruggable targets.

  • Degrader
  • Stabilizer/Modulator
  • Blocker

Technology

AI-driven precision to discover novel targets and develop better drugs

GlueHunter
Powering the next generation of precision small-molecule therapeutics

Unlocks neo-degradable targets and designs molecular glues through advanced complementary pattern analysis

View more
LeadHunter
Revealing the hidden layers of target–drug interactions

Pinpoints therapeutically potent patterns through atomic-level 3D mapping of dynamic protein structures

View more
ERST-LAB
Turning predictions into proof—at speed

Delivers full-cycle validation, from in silico design to in vivo results, with real-time AI feedback for smarter, faster drug discovery

View more

Pipeline

Translating Science into Breakthrough Medicines

View more

Broadening the landscape of druggable targets and disease areas to deliver transformative treatments

News & Notice

View more